Amgen to pay J&J $200 million to settle antitrust suit
LOS ANGELES (Reuters) - Amgen Inc said on Friday it will pay Johnson & Johnson $200 million to settle litigation alleging drug discounts offered by Amgen to cancer clinics violated antitrust laws.
<p>You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~a/reuters/businessNews?i=ybZOgo" border="0)
</img>
</p><div class="feedflare">
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/businessNews?i=YA7KAJ" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/businessNews?i=uZX3jj" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/businessNews?i=mDR6ej" border="0)
</img>
</div>
![](http://feeds.reuters.com/~r/reuters/businessNews/~4/333108444" height="1" width="1)
You are not allowed to view links.
Register or
Login
